RVTY logo

Revvity Inc. (RVTY)

$147.79

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on RVTY

Market cap

$16.50B

EPS

2.25

P/E ratio

73.7

Price to sales

5.91

Dividend yield

0.189%

Beta

1.080399

Price on RVTY

Previous close

$148.85

Today's open

$149.22

Day's range

$146.84 - $151.43

52 week range

$81.22 - $171.74

Profile about RVTY

CEO

Prahlad R. Singh

Employees

11000

Headquarters

Waltham, MA

Exchange

New York Stock Exchange

Shares outstanding

111638757

Issue type

Common Stock

RVTY industries and sectors

Healthcare

Biotechnology & Life Sciences

News on RVTY

Diamond Hill Mid Cap Strategy Q3 2026 Portfolio Review

The Strategy declined 3.83% (net of fees) and the Russell Midcap Index declined 3.00%. Key contributors include Illumina, Revvity and Waystar. Key detractors include Regal Rexnord, Rocket Companies and Red Rock Resorts.

news source

Seeking Alpha • 6 minutes ago

news preview

Revvity, Inc. (RVTY) Presents at Jefferies Global Healthcare Conference 2026 Transcript

Revvity, Inc. (RVTY) Presents at Jefferies Global Healthcare Conference 2026 Transcript

news source

Seeking Alpha • Nov 17, 2026

news preview

Revvity to Showcase Strategy for Powering Scientific Intelligence at 2026 Investor Day

WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY) today will host its 2026 Investor Day, highlighting the Company's differentiated portfolio of Life Sciences and Diagnostics solutions, as well as its position at the intersection of biology, experimentation and data. Under the theme "Powering Scientific Intelligence," Prahlad Singh, president and chief executive officer, and members of Revvity's senior leadership team will outline the Company's strategic priorities, recent operational.

news source

Business Wire • Nov 13, 2026

news preview

ELV or RVTY: Which Is the Better Value Stock Right Now?

Investors interested in Medical Services stocks are likely familiar with Elevance Health (ELV) and Revvity (RVTY). But which of these two companies is the best option for those looking for undervalued stocks?

news source

Zacks Investment Research • Nov 11, 2026

news preview

All You Need to Know About Revvity (RVTY) Rating Upgrade to Buy

Revvity (RVTY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

news source

Zacks Investment Research • Nov 6, 2026

news preview

Madison Mid Cap Fund Q3 2026 Portfolio Activity

The Madison Mid Cap Fund (Class I) returned -2.09% in the third quarter, compared to the Russell Midcap Index return of -3.00%. The top five contributors for the quarter were Gartner, Medpace Holdings, Ross Stores, Revvity, and Waters Corporation. The bottom five detractors for the quarter were MKS, Floor & Decor Holdings, Carlisle Companies, Moelis and Co., and Glacier Bancorp.

news source

Seeking Alpha • Nov 6, 2026

news preview

Revvity Q3 Earnings Call Highlights

Revvity NYSE: RVTY reported third-quarter results that exceeded its expectations, supported by stronger demand in its Life Sciences segment, continued growth in Diagnostics and expanding interest in artificial intelligence-related research tools.

news source

MarketBeat • Nov 4, 2026

news preview

Revvity Faced Off With 'Elevated Investor Expectations' — And Won

Medical research stock Revvity surged on the back of a strong third-quarter report and heightened 2026 view.

news source

Investors Business Daily • Nov 3, 2026

news preview

Revvity, Inc. (RVTY) Q3 2026 Earnings Call Transcript

Revvity, Inc. (RVTY) Q3 2026 Earnings Call Transcript

news source

Seeking Alpha • Nov 3, 2026

news preview

Revvity Announces Financial Results for the Third Quarter of 2026

WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), today reported financial results for the third quarter ended October 4, 2026. The Company reported GAAP earnings per share from continuing operations of $0.56, as compared to $0.41 in the same period a year ago. Revenue for the quarter was $729 million, as compared to $699 million in the same period a year ago. GAAP operating income from continuing operations for the quarter was $95 million, as compared to $82 million for the same per.

news source

Business Wire • Nov 3, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Revvity Inc.

Open an M1 investment account to buy and sell Revvity Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in RVTY on M1